前列腺癌：我们是过度诊断了——还是思考不足？ - Suppr

Suppr

超能文献

Prostate Cancer: Are We Over-Diagnosing-or Under-Thinking?

作者信息

Jones J Stephen

出版信息

Eur Urol. 2008 Jan;53(1):10-2. doi: 10.1016/j.eururo.2007.08.045. Epub 2007 Sep 14.

DOI:10.1016/j.eururo.2007.08.045

PMID:17868978

Abstract

摘要

相似文献

Prostate Cancer: Are We Over-Diagnosing-or Under-Thinking?

Eur Urol. 2008 Jan;53(1):10-2. doi: 10.1016/j.eururo.2007.08.045. Epub 2007 Sep 14.

Prostate cancer screening "reloaded".

Can J Urol. 2010 Apr;17(2):5057.

Verification bias in screening for prostate cancer.

N Engl J Med. 2003 Oct 23;349(17):1672-3; author reply 1672-3.

How should PSA screening efforts be focused to prevent underdiagnosis and overdiagnosis of prostate cancer?

Nat Clin Pract Urol. 2008 Apr;5(4):172-3. doi: 10.1038/ncpuro1051. Epub 2008 Mar 4.

The challenges of prostate cancer detection. Interview by Carren Bersch.

MLO Med Lab Obs. 2004 Feb;36(2):26, 30-1.

Limitations and use of PSA derivatives in the screening and risk stratification of prostate cancer.

Urol Oncol. 2009 Nov-Dec;27(6):583-4. doi: 10.1016/j.urolonc.2009.06.011.

Re: Is a screening interval of every 4 years for prostate cancer acceptable?

J Natl Cancer Inst. 2008 Feb 6;100(3):222; author reply 223-4. doi: 10.1093/jnci/djm293. Epub 2008 Jan 29.

Prostate-specific antigen screening for prostate cancer: a decision-analytical perspective.

BJU Int. 2007 Sep;100(3):486-8. doi: 10.1111/j.1464-410X.2007.07055.x.

Prostate cancer screening.

BJU Int. 2004 Nov;94(7):964-6. doi: 10.1111/j.1464-410X.2004.05187.x.

Application of prostate-specific antigen in prostate cancer.

MLO Med Lab Obs. 2008 Oct;40(10):54, 56-7.

引用本文的文献

A modified sampling method for the precise detection of prostate cancer tissues using a three-dimensional stereotaxic location technique.

Quant Imaging Med Surg. 2024 Sep 1;14(9):6724-6733. doi: 10.21037/qims-23-1820. Epub 2024 Aug 28.

[Fifteen-year results of the ProtecT study-commentary].

Urologie. 2023 Jun;62(6):628-630. doi: 10.1007/s00120-023-02114-4. Epub 2023 May 31.

Saturation biopsies for prostate cancer: current uses and future prospects.

Nat Rev Urol. 2009 Dec;6(12):645-52. doi: 10.1038/nrurol.2009.213. Epub 2009 Nov 10.

Active surveillance or active treatment in localized prostate cancer?

Dtsch Arztebl Int. 2009 May;106(22):371-6. doi: 10.3238/arztebl.2009.0371. Epub 2009 May 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Prostate Cancer: Are We Over-Diagnosing-or Under-Thinking?

Eur Urol. 2008 Jan;53(1):10-2. doi: 10.1016/j.eururo.2007.08.045. Epub 2007 Sep 14.

Prostate cancer screening "reloaded".

Can J Urol. 2010 Apr;17(2):5057.

Verification bias in screening for prostate cancer.

N Engl J Med. 2003 Oct 23;349(17):1672-3; author reply 1672-3.

How should PSA screening efforts be focused to prevent underdiagnosis and overdiagnosis of prostate cancer?

Nat Clin Pract Urol. 2008 Apr;5(4):172-3. doi: 10.1038/ncpuro1051. Epub 2008 Mar 4.

The challenges of prostate cancer detection. Interview by Carren Bersch.

MLO Med Lab Obs. 2004 Feb;36(2):26, 30-1.

Limitations and use of PSA derivatives in the screening and risk stratification of prostate cancer.

Urol Oncol. 2009 Nov-Dec;27(6):583-4. doi: 10.1016/j.urolonc.2009.06.011.

Re: Is a screening interval of every 4 years for prostate cancer acceptable?

J Natl Cancer Inst. 2008 Feb 6;100(3):222; author reply 223-4. doi: 10.1093/jnci/djm293. Epub 2008 Jan 29.

Prostate-specific antigen screening for prostate cancer: a decision-analytical perspective.

BJU Int. 2007 Sep;100(3):486-8. doi: 10.1111/j.1464-410X.2007.07055.x.

Prostate cancer screening.

BJU Int. 2004 Nov;94(7):964-6. doi: 10.1111/j.1464-410X.2004.05187.x.

Application of prostate-specific antigen in prostate cancer.

MLO Med Lab Obs. 2008 Oct;40(10):54, 56-7.

引用本文的文献

A modified sampling method for the precise detection of prostate cancer tissues using a three-dimensional stereotaxic location technique.

Quant Imaging Med Surg. 2024 Sep 1;14(9):6724-6733. doi: 10.21037/qims-23-1820. Epub 2024 Aug 28.

[Fifteen-year results of the ProtecT study-commentary].

Urologie. 2023 Jun;62(6):628-630. doi: 10.1007/s00120-023-02114-4. Epub 2023 May 31.

Saturation biopsies for prostate cancer: current uses and future prospects.

Nat Rev Urol. 2009 Dec;6(12):645-52. doi: 10.1038/nrurol.2009.213. Epub 2009 Nov 10.

Active surveillance or active treatment in localized prostate cancer?

Dtsch Arztebl Int. 2009 May;106(22):371-6. doi: 10.3238/arztebl.2009.0371. Epub 2009 May 29.